API
< Back to situations

[ORGANIZATION]

SIDeMaST

Featured in 12 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [IT]

Sidemast hidradenitis suppurativa awareness campaign

2 clusters · 2 sources · last updated

Latest: Italy hosts free dermatological consultations for hidradenitis suppurativa

The Italian Society of Dermatology and Sexually Transmitted Diseases (Sidemast) launched a national awareness campaign titled ‘Scritto sulla pelle’ (Written on the Skin) to address hidradenitis suppurativa (Hs), a chroni

[ACTIVE] [HEALTH] [MX] [ES] [AR]

Global cancer prevention and patient support initiatives

11 clusters · 113 sources · last updated

Latest: Hidalgo implements social programs and healthcare support

Global health initiatives continue to focus on cancer prevention, early detection, and survivor support across Latin America and Europe. In Spain, medical experts at the 48th SEMERGEN National Congress noted that while s

[QUIET] [HEALTH] [IT]

Sexual health and wellness initiatives in Italy

2 clusters · 10 sources · last updated

Latest: Italy hosts free sexual wellness consultations in Treviso, Bari, and Taverna

In late September 2026, Fondazione Foresta ETS organized free, anonymous rapid testing for HIV and syphilis in Piazza Portello, Padova. The event, held in collaboration with Padova Sex Lab, targeted university students t

[QUIET] [HEALTH] [ES] [IT] [CZ]

Hair health and seasonal shedding factors

8 clusters · 27 sources · last updated

Latest: Dermatologists link intense autumn hair loss to summer UV exposure

Discussions regarding hair health focus on the impact of seasonal changes, nutritional intake, and psychological stress. The transition to autumn in September and October can lead to increased hair shedding as part of th

[QUIET] [HEALTH] [CN] [EU] [IT]

Upadacitinib expanded approval for skin and arthritis

4 clusters · 22 sources · last updated

Latest: European Commission approves upadacitinib for three immune-mediated diseases

Clinical trials for the Janus kinase (JAK) inhibitor upadacitinib have demonstrated success in treating severe alopecia areata by blocking inflammatory signals via the JAK/STAT pathway. Research indicates that up to 23 p

Also covered in